{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:31:18Z","timestamp":1772166678155,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancers Head Neck"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We conducted a correlative study for E2399, a function preservation trial for resectable locally advanced oropharynx and larynx cancer, to prospectively assess effects of chemoradiation (CCR) on quality of life (QOL), swallowing and voice. We correlated the results of swallow assessments done via questionnaires and objective assessments\u00a0by modified barium swallow (MBS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Functional Assessment of Cancer-HN (FACT-HN), the Performance Status Scale \u2013 Head and Neck (PSS-HN), swallow assessments (including modified barium swallow studies), and voice assessments: Voice Handicap Index (VHI), the Voice Disability Assessment (VDA), and American Speech-Language Hearing Association\u2019s Functional Communication Measure (FCM) were conducted at baseline and periodically post-treatment for 2\u2009years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline QOL and swallowing function predicted overall survival. Patients experienced a marked decrease in QOL, swallowing, and speech post CCR although the decrease in vocal function was modest. Function and QOL returned towards baseline in the majority of patients by 12\u2009months post treatment. Less than 10% of patients had severe dysphagia and were PEG dependent at 12\u2009months post treatment. There was a high degree of correlation between the FACT-HN and PSS-HN swallow items. Statistically significant correlations were found between subjective and objective measures of swallow function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients experience marked loss in swallowing function post CCR which returned to baseline in the majority of patients. The correlations between the FCM and self-report swallow items on the PSS and FACT-HN appear to be sufficiently strong to justify their use as a surrogate marker for swallowing disability in large therapeutic trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41199-020-00059-1","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T15:02:32Z","timestamp":1608649352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["ECOG-ACRIN 2399: analysis of patient related outcomes after Chemoradiation for locally advanced head and neck Cancer"],"prefix":"10.1186","volume":"5","author":[{"given":"Anthony","family":"Cmelak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Ridner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene","family":"Forastiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Burtness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"59_CR1","doi-asserted-by":"crossref","unstructured":"Forastiere AA, Trotti A, Pfister DG, Grandis JR. Head and neck cancer: recent advances and new standards of care. J Clin Oncol 2006;24(17):2603\u20135. PMID:16763271.","DOI":"10.1200\/JCO.2006.07.1464"},{"key":"59_CR2","doi-asserted-by":"crossref","unstructured":"Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys. 2000; 47(1): 1\u201312. PMID 10758302.","DOI":"10.1016\/S0360-3016(99)00558-1"},{"key":"59_CR3","doi-asserted-by":"crossref","unstructured":"Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, Humerickhouse R, Dolan ME, Pelzer H, Sulzen L, Witt ME, Hsieh YC, Mittal BB, Weichselbaum RR. Concomitant chemoradiotherapy as primary therapy for Locoregionally advanced head and neck cancer. J Clin Oncol. 2000; 18(8): 1652\u201361. PMID 10764425.","DOI":"10.1200\/JCO.2000.18.8.1652"},{"issue":"1","key":"59_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-0347(199601\/02)18:1<1::AID-HED1>3.0.CO;2-7","volume":"18","author":"MA List","year":"1996","unstructured":"List MA, Ritter-Sterr CA, Baker TM, Colangelo LA, Matz G, Pauloski BR, Logemann JA. Longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck. 1996;18(1):1\u201310 PMID 8774916.","journal-title":"Head Neck"},{"issue":"3","key":"59_CR5","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1200\/JCO.1999.17.3.1008","volume":"17","author":"K Bjordal","year":"1999","unstructured":"Bjordal K, Hammerlid E, Ahlner-Elmqvist M, Boysen M, Evensen JF, Bi\u00f6rklund A, de Leeuw JRJ, Fayers PM, Thomas W, Kaasa S. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questinnaire-H&N35. J Clin Oncol. 1999;17(3):1008\u201319 PMID 10071296.","journal-title":"J Clin Oncol"},{"issue":"25","key":"59_CR6","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2007.10.8951","volume":"25","author":"AJ Cmelak","year":"2007","unstructured":"Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA. Locally advanced Resectable larynx (L) or oropharynx (OP) Cancer: results of phase II organ preservation trial E2399. J Clin Oncol. 2007;25(25):3971\u20137 PMID: 17761982.","journal-title":"J Clin Oncol"},{"issue":"4","key":"59_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive had and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261\u20139 PMID 18270337.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"59_CR8","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S","volume":"77","author":"MA List","year":"1996","unstructured":"List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy \u2013 head and neck scale. A study of utility and validity. Cancer. 1996;77(11):2294\u2013301 PMID 8635098.","journal-title":"Cancer"},{"issue":"3","key":"59_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/1097-0347(200103)23:3<201::AID-HED1019>3.0.CO;2-M","volume":"23","author":"J Ringash","year":"2001","unstructured":"Ringash J, Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck. 2001;23(3):201\u201313 PMID 11428450.","journal-title":"Head Neck"},{"issue":"5","key":"59_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archotol.1996.01890170018005","volume":"122","author":"LL D'Antonio","year":"1996","unstructured":"D'Antonio LL, Zimmerman GJ, Cella DF, Long SA. Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1996;122(5):482\u20137 PMID 8615964.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"9 Pt 1","key":"59_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/00005537-199609000-00008","volume":"106","author":"SA Long","year":"1996","unstructured":"Long SA, D'Antonio LL, Robinson EB, Zimmerman G, Petti G, Chonkich G. Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope. 1996;106(9 Pt 1):1084\u20138 PMID 8822710.","journal-title":"Laryngoscope"},{"issue":"3","key":"59_CR12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1200\/JCO.1999.17.3.1020","volume":"17","author":"MA List","year":"1999","unstructured":"List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K, Vokes EE. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 1999;17(3):1020\u20138 PMID 10071297.","journal-title":"J Clin Oncol"},{"key":"59_CR13","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1097\/01.mlg.0000147932.36885.9e","volume":"11","author":"TK Meyer","year":"2004","unstructured":"Meyer TK, Kuhn JC, Campbell BH, Marbella AM, Myers KB, Layde PM. Speech intelligibility and quality of life in head and neck cancer survivors. Laryngoscope. 2004;11:1977\u201381 PMID 15510026.","journal-title":"Laryngoscope"},{"issue":"2","key":"59_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0360-3016(96)00319-7","volume":"36","author":"GJ Moore","year":"1996","unstructured":"Moore GJ, Parsons JT, Mendenhall WM. Quality of life outcomes after primary radiotherapy for squamous cell carcinoma of the base of tongue. Int J Radiat Oncol Biol Phys. 1996;36(2):351\u20134 PMID 8892459.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"59_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/1097-0142(19900801)66:3<564::AID-CNCR2820660326>3.0.CO;2-D","volume":"66","author":"MA List","year":"1990","unstructured":"List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer. 1990;66(3):564\u20139 PMID 2364368.","journal-title":"Cancer"},{"issue":"2","key":"59_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.0307-7772.2004.00775.x","volume":"29","author":"JA Wilson","year":"2004","unstructured":"Wilson JA, Webb A, Carding PN, Steen IN, MacKenzie K, Deary IJ. The voice symptom scale (VoiSS) and the vocal handicap index (VHI): a comparison of structure and content. Clin Otolaryngol Allied Sci. 2004;29(2):169\u201374. PMID 15113305.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"59_CR17","doi-asserted-by":"crossref","unstructured":"Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head Neck. 2019;41(2):479\u201387. PMID 30536748.","DOI":"10.1002\/hed.25412"},{"key":"59_CR18","doi-asserted-by":"crossref","unstructured":"Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. J Voice. 1998;12(4):540\u201350. PMID 9988041.","DOI":"10.1016\/S0892-1997(98)80063-5"},{"issue":"10166","key":"59_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","volume":"393","author":"ML Gillison","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, RCK J, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy Plus Cetuximab or Cisplatin in Human Papillomavirus-Positive Oropharyngeal Cancer (NRG Oncology RTOG 1016): A Randomized, Multicentre, Non-Inferiority Trial. Lancet. 2019;393(10166):40\u201350. PMID 30449625.","journal-title":"Lancet"}],"container-title":["Cancers of the Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41199-020-00059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41199-020-00059-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41199-020-00059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T20:19:19Z","timestamp":1697401159000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancersheadneck.biomedcentral.com\/articles\/10.1186\/s41199-020-00059-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1186\/s41199-020-00059-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-33337\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33337\/v2","asserted-by":"object"}]},"ISSN":["2059-7347"],"issn-type":[{"value":"2059-7347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the individual IRBs from ECOG-ACRIN participating institutions. Informed consent for participation was obtained from all study patients prior to enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All listed authors and ECOG-ACRIN have given permission to Cancers of the Head and Neck to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}